FMO5 and chronic granulomatous disease: In fact, an impaired NADPH oxidase activity is a well-known risk factor to develop invasive aspergillosis and other life threatening diseases, as seen in Chronic Granulomatous Disease (CGD) patients (Cohen et al., 1981; King et al., 2016; Segal and Romani, 2009).